Original Research
Accepted on 15 Dec 2025
METTL3 inhibition alleviates neuroinflammation and apoptosis by reducing ETV4 m6A modification
in Inflammation
Original Research
Accepted on 15 Dec 2025
in Inflammation
Review
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Mini Review
Accepted on 15 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Review
Accepted on 15 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Case Report
Accepted on 15 Dec 2025
in Primary Immunodeficiencies
Original Research
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 Dec 2025
in NK and Innate Lymphoid Cell Biology
Original Research
Accepted on 15 Dec 2025
in Cytokines and Soluble Mediators in Immunity
Original Research
Accepted on 15 Dec 2025
in Inflammation
Editorial
Accepted on 15 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Original Research
Accepted on 15 Dec 2025
in Vaccines and Molecular Therapeutics
Review
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 Dec 2025
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 15 Dec 2025
in Vaccines and Molecular Therapeutics
Original Research
Accepted on 15 Dec 2025
in NK and Innate Lymphoid Cell Biology
Review
Accepted on 15 Dec 2025
in Vaccines and Molecular Therapeutics
Review
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 Dec 2025
in Primary Immunodeficiencies
Original Research
Accepted on 15 Dec 2025
in Autoimmune and Autoinflammatory Disorders : Autoimmune Disorders
Mini Review
Accepted on 15 Dec 2025
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 15 Dec 2025
in Autoimmune and Autoinflammatory Disorders: Autoinflammatory Disorders
Original Research
Accepted on 15 Dec 2025
in Multiple Sclerosis and Neuroimmunology